Shanghai Raas Blood Products Company Limited operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Raas Blood Products Company Limited with three other
companies in this sector in China:
China Biologic Products, Inc.
sales of 2.27 billion Chinese Renmimbi [US$329.64 million]
of which 100%
was Human Blood Product),
Tonghua Dongbao Medicines Company Limited
(2.03 billion Chinese Renmimbi [US$294.78 million]
of which 96%
was Pharmaceutical), and
Beijing Tiantan Biologic.
(2.10 billion Chinese Renmimbi [US$304.30 million]
of which 99%
was Biological products industry).
During the year ended December of 2016, sales at
Shanghai Raas Blood Products Company Limited were 2.33 billion Chinese Renmimbi (US$337.82 million).
increase of 15.5%
versus 2015, when the company's sales were 2.01 billion Chinese Renmimbi.
This was the third consecutive year of growth at Shanghai Raas Blood Products Company Limited.
Sales of Other Operating saw an increase
that was more than double the company's growth rate: sales were up
437.8% in 2016, from
2.09 million Chinese Renmimbi to 11.25 million Chinese Renmimbi.